The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

3 May 2012 07:00

RNS Number : 6214C
Sopheon PLC
03 May 2012
 



Embargoed Release: 07:00hrs Thursday 3 May 2012

 

 

SOPHEON PLC

("Sopheon" or the "Company")

 

INTERIM MANAGEMENT STATEMENT

 

Sopheon plc, the international provider of software and services that improve the financial return from innovation and product development investments, announces its first interim management statement for the period from1 January 2012 to the date of this announcement, in line with the requirements of the EU Transparency Directive.

 

After the good start to the year which we highlighted in our 2011 results announcement, sales activities have continued to increase. Highlights for the year to date include:

 

14 new and extension license orders achieved, in addition to a number of substantial services engagements. Business from existing customers remains strong, and a number of new customers have also been won. Revenue visibility for the full year from contracted business and recurring revenue streams now stands above £6.5 million, compared to £6.1 million a year ago. We expect to close additional business in the second quarter from a mix of new and existing customers. Services business remains strong, already absorbing new hires made in the first quarter.

  

We advanced our market presence across Europe with the addition of two sales representatives, building on the recent appointment of Jim Conroy as our European commercial leader. These additional hires were made with due caution given that global markets have not yet regained their poise and accurate prediction of the timing and value of individual sales remains challenging.

 

A major product milestone was achieved with the release of Accolade 8.0, the latest version of our flagship software solution. This landmark release offers enhanced support for project portfolio management and collaboration, integration with Microsoft's SharePoint® technology and a mobile application designed for use with iPhone® and iPad®.devices. Other features deepen our software's ease-of-configuration and ease-of-use. Reflecting input from a number of high-profile customers, we believe Accolade 8.0 sets a new standard for agility in managing innovation.

 

On the corporate front, Sopheon is actively considering the transfer of its listing from the regulated market operated by NYSE Euronext in Amsterdam to its exchange-regulated market, NYSE Alternext in Amsterdam. This would enable the Company to benefit from certain tax exemptions which the Board believe will make it more attractive to specialist investment funds. It will also reduce the regulatory burden associated with a fully regulated market like NYSE Euronext which the Board and its advisers consider to be disproportionate to a company of Sopheon's size and resources. NYSE Alternext is a well-recognized market with over 180 companies listed, representing a combined market capitalization of €5.9 billion. Since NYSE Alternext uses the same trading platform as NYSE Euronext, no change is expected to the mechanisms by which shareholders can buy and sell Sopheon shares. A resolution will be put to shareholders in connection with this proposed transfer at the forthcoming Annual General Meeting of the company, to be held at the offices of Squire Sanders (UK) LLP, 7 Devonshire Square, London EC2M 4YH on 13 June 2012 at 11:00am.  

 

Accolade® is a registered trademark of Sopheon plc. SharePoint® is a registered trademark of Microsoft Corporation. iPhone® and iPad®

are registered trademarks of Apple®

For further information contact:

 

Barry Mence, Chairman

Sopheon plc

Tel : + 44 (0) 1483 685 735

Arif Karimjee, CFO

Sopheon plc

Tel : + 44 (0) 1483 685 735

Charlotte Stranner/ Henrik Persson/ Victoria Bates

finnCap

Tel: +44 (0) 20 7600 1658

Guy McDougall/Heather Armstrong

Newgate Threadneedle

Tel : + 44 (0) 20 7653 9850

Claire Verhagen

Citigate First Financial

Tel : + 31 (0) 205 754 010

 

About Sopheon

Sopheon (LSE: SPE) is an international provider of software and services. Sopheon's solutions structure, align and manage innovation processes to help organizations generate more revenues and profits from new products. Sopheon's solutions are used by industry leaders throughout the world, including BAE Systems, BASF, Corning, Electrolux, Honeywell, Novartis and SABMiller. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEAKSAEDXAEFF
Date   Source Headline
30th Jan 201810:27 amRNSIssue of Equity
29th Jan 20187:00 amRNSTrading Update
4th Jan 20182:05 pmRNSSecond Price Monitoring Extn
4th Jan 20182:00 pmRNSPrice Monitoring Extension
4th Jan 20187:00 amRNSTrading Update
22nd Dec 20171:01 pmRNSHolding(s) in Company
22nd Dec 201712:37 pmRNSConversion of Loan Stock
8th Dec 20177:00 amRNSAmendment to the Terms of Convertible Loan Stock
9th Nov 20177:00 amRNSCertis Europe Partners with Sopheon
19th Oct 20177:00 amRNSSopheon Funding Award
11th Oct 201710:44 amRNSDirector/PDMR Shareholding
2nd Oct 20177:00 amRNSIssue of Equity
26th Sep 20177:00 amRNSSopheon "Leader" in Strategic Portfolio Management
5th Sep 20177:00 amRNSSopheon's Accolade Software beyond innovation
24th Aug 20177:00 amRNSHalf Yearly Report
21st Jul 201710:32 amRNSDirector Shareholdings
6th Jul 20177:00 amRNSAccolade Release 11.2
29th Jun 20177:00 amRNSNew Approach to Product Development with Accolade
13th Jun 201712:04 pmRNSDirector Shareholdings
8th Jun 201712:09 pmRNSResult of AGM
8th Jun 20177:00 amRNSAGM Statement
26th May 20174:33 pmRNSIssue of Equity
26th Apr 20173:50 pmRNSIssue of Equity
12th Apr 201712:01 pmRNSIssue of Equity
7th Apr 20171:37 pmRNSDirector Shareholdings
31st Mar 20177:00 amRNSDirector Shareholdings
31st Mar 20177:00 amRNSIssue of Equity
23rd Mar 20177:00 amRNSFinal Results
23rd Feb 20177:00 amRNSAccolade Release 11.1
16th Feb 20177:00 amRNSGrant of Options / PDMR dealing
30th Jan 20177:00 amRNSTrading Update
21st Nov 201611:50 amRNSIssue of Equity
3rd Nov 20168:00 amRNSAccolade Release 11.0
29th Sep 201612:41 pmRNSIssue of Equity
22nd Sep 20169:09 amRNSIssue of Equity
15th Sep 20163:09 pmRNSIssue of Equity
25th Aug 20167:00 amRNSHalf Yearly Report
28th Jul 20165:01 pmRNSHolding(s) in Company
26th Jul 201610:49 amRNSHolding(s) in Company
12th Jul 201610:48 amRNSHolding(s) in Company
29th Jun 20165:32 pmRNSDirector Dealing
16th Jun 20164:22 pmRNSDirector Dealing
14th Jun 20164:18 pmRNSDirector Dealing
10th Jun 20162:13 pmRNSDirector Dealing
9th Jun 201611:37 amRNSResult of AGM
9th Jun 20167:00 amRNSAGM Statement
31st May 20163:09 pmRNSIssue of Equity
5th May 20161:25 pmRNSHolding(s) in Company
4th May 20167:00 amRNSAccolade Release 10.3
3rd May 20161:27 pmRNSDirector Shareholdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.